Login

the Future of Wireless Connectivity | Murray Wright, CEO AT TESSCO Technologies Inc 00:10:00

Share On Facebook Share On Twitter

Murray Wright is the CEO AT TESSCO Technologies Inc

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Ameresco Manchester City Council, UK | Sakellaris, P.E., CEO, Ameresco IncAMRC:NYQ
00:10:00
Lundin Gold at One-to-One Conference: Financing Success and Future Plans for the Fruta del Norte Project
00:10:00
Expansion of Renewable Energies and Business Prospects | Peter Szabo , CEO, Energiekontor AG .
00:10:00
From Humble Beginnings to Success: Meet Lalit Dangi, Chairman of Liquid Group|Mr. Lalit Kumar Dangi,Chairman,Libord Securities Ltd.
00:00:00
Aortic Valve Disease: What causes it and how is it treated / Jeremy J. Thaden, M.D. Cardiologist, Mayo Clinic
00:10:00
Venture capital firm that invests in start-ups that apply data and technology to disrupt existing industries|David Waxman,Managing Partner,TenOneTen Ventures
00:10:00
Cenergy Holdings: €0.08 dividend per share with a €3 billion backlog | Alexios Alexiou, CEO, Cenergy Holdings SACENER:BRU
00:10:00
Stephen Schwarzman Discusses Real Estate Opportunities, U.S.-China Relations, and Presidential Politics | Stephen A. Schwarzman, CEO , The Blackstone Group Inc.
00:10:00
Matthew Lamont Discusses DUG Technology's Role in Revolutionizing High-Performance Computing | Matthew Lamont, Managing Director , Dug Technology Ltd.
00:00:00
The vast global opportunity for the Maxigesic painkiller - Dr Hartley Atkinson Chief Executive Officer, Executive Director and Co-Founder, AFT Pharmaceuticals Ltd
00:10:00
F&C Lecture: Navigating Alternative Investments | Paul Niven, Manager, F&C Investment Trust
00:10:00
Shane Gannon Takes the Helm as CFO at Mirvac Group (ASX:MGR)

© 2026 Nehu